CHLORDIAZACHEL Drug Patent Profile
✉ Email this page to a colleague
When do Chlordiazachel patents expire, and when can generic versions of Chlordiazachel launch?
Chlordiazachel is a drug marketed by Rachelle and is included in three NDAs.
The generic ingredient in CHLORDIAZACHEL is chlordiazepoxide hydrochloride. There are nine drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the chlordiazepoxide hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Chlordiazachel
A generic version of CHLORDIAZACHEL was approved as chlordiazepoxide hydrochloride by CHARTWELL RX on December 31st, 1969.
Summary for CHLORDIAZACHEL
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 3 |
Raw Ingredient (Bulk) Api Vendors: | 31 |
Patent Applications: | 2,593 |
Formulation / Manufacturing: | see details |
DailyMed Link: | CHLORDIAZACHEL at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for CHLORDIAZACHEL
US Patents and Regulatory Information for CHLORDIAZACHEL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Rachelle | CHLORDIAZACHEL | chlordiazepoxide hydrochloride | CAPSULE;ORAL | 085086-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Rachelle | CHLORDIAZACHEL | chlordiazepoxide hydrochloride | CAPSULE;ORAL | 084639-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Rachelle | CHLORDIAZACHEL | chlordiazepoxide hydrochloride | CAPSULE;ORAL | 085087-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |